Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 23Breast Neoplasms 22Colorectal Neoplasms 14Ovarian Neoplasms 12Lung Neoplasms 10Neoplasm Metastasis 9Stomach Neoplasms 8Neoplasms 8Nasopharyngeal Carcinoma 8Leukemia, Myeloid, Acute 7Triple Negative Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Rectal Neoplasms 6Fallopian Tube Neoplasms 6Recurrence 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Esophageal Squamous Cell Carcinoma 5Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Lymphoma, Non-Hodgkin 4Leukemia 4Head and Neck Neoplasms 4Esophageal Neoplasms 4Carcinoma, Ovarian Epithelial 4Pancreatic Neoplasms 3Neoplasms by Site 3Lymphoma, Large B-Cell, Diffuse 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Multiple Myeloma 2

Interventions

trilaciclib 1Surgical Procedures, Operative 1Sodium Chloride 1Radiotherapy 1Magnetic Resonance Spectroscopy 1Glucose 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Limited Stage Small Cell Lung Cancer × Drug Therapy × Clear all
NCT05496166 2023-05-17

The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 3 Not yet recruiting
348 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡